Unusual and early hyperglycemia following amiodarone infusion in two infants.
Amiodarone is an effective antiarrhythmic agent that is widely used for tachyarrhythmias, especially ventricular tachycardia and supraventricular tachycardia. It has some mild short-term (e.g., skin rashes, gastrointestinal symptoms, and corneal microdeposits) and long-term side effects (thyroid dysfunction, visual disturbances, pulmonary infiltrates, ataxia, and hepatitis). We present two infants who had hyperglycemia following amiodarone infusion during the early postoperative period.
Yildirim
S V
SV
Division of Pediatric Cardiology, Baskent University, Faculty of Medicine, Ankara, Turkey. svefay@yahoo.com
Azak
E
E
Varan
B
B
Tokel
K
K
D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D006348:Cardiac Surgical Procedures; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000601:surgery; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000209:etiology; D014188:Transposition of Great Vessels / Q000601:surgery; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone